Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
46 participants
INTERVENTIONAL
2009-07-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intrathecal morphine 0.1 mg
After routine monitorisation, intravenous cannulation and premedication, patients in this group will receive a spinal anaesthesia with 0.1 mg morphine combined with 7.5 mg heavy bupivacaine
intrathecal morphine 0.1 mg combined with intrathecal heavy bupivacaine 7.5 mg
standard monitoring with Datex Ohmeda anesthesia monitor, GE, Finland
electrocardiography, heart rate, pulse oximetry and noninvasive arterial blood pressure
intravenous cannulation and premedication
18-gauge intravenous cannula was inserted at the forearm opposite to the surgical side and routine iv premedication (midazolam 0.03 mg/kg) was given
0.4 mg of intrathecal morphine
After routine monitorisation, intravenous cannulation and premedication, patients in this group will receive spinal anesthesia with 0.4 mg of morphine combined with 7.5 mg of heavy bupivacaine.
intrathecal morphine 0.4 mg combined with intrathecal heavy bupivacaine 7.5 mg
standard monitoring with Datex Ohmeda anesthesia monitor, GE, Finland
electrocardiography, heart rate, pulse oximetry and noninvasive arterial blood pressure
intravenous cannulation and premedication
18-gauge intravenous cannula was inserted at the forearm opposite to the surgical side and routine iv premedication (midazolam 0.03 mg/kg) was given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intrathecal morphine 0.1 mg combined with intrathecal heavy bupivacaine 7.5 mg
intrathecal morphine 0.4 mg combined with intrathecal heavy bupivacaine 7.5 mg
standard monitoring with Datex Ohmeda anesthesia monitor, GE, Finland
electrocardiography, heart rate, pulse oximetry and noninvasive arterial blood pressure
intravenous cannulation and premedication
18-gauge intravenous cannula was inserted at the forearm opposite to the surgical side and routine iv premedication (midazolam 0.03 mg/kg) was given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-65 years
* undergoing elective unilateral open inguinal hernia repair surgery
Exclusion Criteria
* central or peripheral neuropathies
* severe respiratory or cardiac diseases
* chronic analgesic use
* history of substance abuse
* allergy to local anesthetics
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basak Ceyda MECO
MD, DESA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Basak Ceyda Meco
Role: PRINCIPAL_INVESTIGATOR
Ankara University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara University Faculty of Medicine, Ibni Sina Hospital general surgery OR
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-02-09
Identifier Type: -
Identifier Source: org_study_id